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Abstract 
Surfactant apoproteins A (SP-A) and B (SP-B) interact with the lipids of surfactant and such protein-lipid interactions may be of 
importance in several of the steps in the surfactant cycle. We analyzed the kinetics of fusion of dipalmitoylphosphatidylcholine-phospha- 
tidylglycerol (DPPC:PG; 7:3, w/w) phospholipid vesicles induced by SP-B alone, in the presence of 5 mM calcium, and in the presence 
of calcium and SP-A. Membrane fusion was measured by the method of resonance nergy transfer between non-exchangeable 
fluorophores incorporated in the membrane. Data were analyzed using a mass action kinetic model for membrane fusion between 
phospholipid vesicles. We found a SP-B dose-dependent increase in lipid mixing within a range of phospholipid concentration f 5 to 100 
/xM. Calcium caused asmall additive increase in lipid mixing, but calcium and SP-A combined markedly increased lipid mixing induced 
by SP-B. Both aggregation and fusion rate constants increased with an increase in the SP-B/lipid ratio. In the presence of calcium and 
SP-A, the number of vesicles per fusion product markedly increased, as did the aggregation rate constants, whereas the fusion rate 
constants remained essentially unchanged. 
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1. Introduction 
Pulmonary surfactant is the 'anti-atelectasis' factor that 
lines the alveolar surface, increasing pulmonary compli- 
ance and stabilizing lung volumes [1]. Although the phos- 
pholipids of surfactant, particularly dipalmitoylphospha- 
tidylcholine (DPPC), form the alveolar surface film, sur- 
factant apoproteins play important, albeit incompletely de- 
fined roles in the intracellular assembly of surfactant and 
in its extracellular metabolism and function (reviewed in 
[2]). 
We previously reported that surfactant apoprotein B 
(SP-B), a 79-amino-acid-long, cationic, amphipathic, 
membrane-associated protein [3], enhanced membrane fu- 
sion between phospholipid liposomes [4]. We showed that 
the liposome membranes underwent extensive mixing, but 
their contents rapidly and completely leaked out. The lipid 
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mixing, measured by energy transfer between fluorescent 
lipid probes, correlated with a structural rearrangement of 
the spherical liposomes into large, stacked sheets, as previ- 
ously reported [5]. These results, coupled with recent 
studies of the intracellular routing and processing of the 
SP-B preprotein [6,7], suggested to us that the fusogenic 
potential of SP-B, released with cleavage of the precursor 
protein, could be critical for the packaging of surfactant 
phospholipids in intracellular lamellar bodies [8]. It has 
also been suggested that SP-B-enhanced fusion of sub- 
phase lipids with the surface film may play a role in the 
adsorption of secreted lamellar body contents to the alveo- 
lar surface [9]. Consistent with both hypotheses, newborns 
with congenital SP-B deficiency have severe respiratory 
distress [10]. The recent discovery of this lethal familial 
point mutation in the SP-B gene [11] gives added impetus 
to establishing the precise functions of SP-B. 
In our earlier studies we reported that surfactant apopro- 
tein A (SP-A) aggregated liposomes [12] but, in contrast to 
SP-B, did not induce lipid mixing [4]. The trafficking of 
SP-A in type II cells has not been well defined, but there is 
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increasing evidence that SP-A may be secreted indepen- 
dent of lamellar bodies [13-15] and then rapidly associate 
with lamellar body contents in the alveolar lining fluid 
[15]. Electron microscopy of the alveolus reveals that the 
membranes released from many different lamellar bodies 
intermingle in forming a three-dimensional l ttice-like ar- 
rangement of tubules known as tubular myelin [16]. The 
precise topology of components in this unusual structure is 
beyond the resolution of the electron microscope, but the 
comers of these tubules, where the bilayers cross and 
merge, are decorated with extramembranous particles [17], 
probably SP-A [18]. Consistent with these trafficking and 
morphological studies both SP-A and SP-B are required to 
form tubular myelin like structures in vitro [5,19]. The 
morphological studies suggest hat membrane aggregation 
and fusion, both directed with long-range order, must be 
involved in the extracellular t ansition from lamellar bod- 
ies to tubular myelin. All current results point to critical 
interdependent roles for SP-A and SP-B, but the precise 
roles of the two apoproteins in the stepwise processes of 
aggregation and fusion in the restructuring of lamellar 
body contents are unclear. 
The studies presented here extend these previous quali- 
tative and morphological descriptions of the effects of 
SP-A and SP-B on the structure of phospholipid liposomes 
by studying a wide range of lipid-protein ratios in an 
established assay of liposome fusion. These studies had 
two aims. First, to determine whether SP-B alone would 
enhance significant membrane fusion in concentrations 
consistent with estimates of the physiological concentra- 
tion in lamellar bodies. Second, to determine whether 
SP-A enhances the fusion of SP-B containing membranes 
solely by the well-characterized ability of this protein to 
cause liposome aggregation. 
previously described methods [4]. Surfactant proteins were 
isolated from the dog and human surfactants using previ- 
ously described methods [21,22]. The surfactant was first 
extracted in 1-butanol (1:50, v /v )  at room temperature and 
then centrifuged twice at 6000 X g,v for 20 min to sedi- 
ment the butanol-insoluble proteins. The resulting pellet 
was dried under N 2 and washed twice in 5 mM Tris/150 
mM NaC1/20 mM octyl /3-D-glucopyranoside (pH 7.4). 
The precipitate was then solubilized in 5 mM Tris buffer 
(pH 7.4), and dialyzed for 48 h against four changes of the 
same buffer. Any insoluble remaining material was re- 
moved by centrifugation at 100000 X gav for 30 min. The 
resulting supernatant containing SP-A was assayed for 
protein content [23] and purity (SDS-PAGE), then stored at 
-20°C. Stock solutions of SP-A (200 /xg/mL) in 5 mM 
Tris were used in all experiments. The hydrophobic protein 
SP-B was purified from the butanol supernatant. The su- 
pernatant was dried by rotary evaporation and resolubi- 
lized in chloroform/methanol/0.1 M HC1 (1:1:0.1; v/v). 
Insoluble material was removed by centrifugation and the 
supernatant was applied to a 3 X 85 cm Sephadex LH 60 
column and eluted at 18 mL/h  using the same solvent at 
room temperature. The eluted fractions were assayed by 
SDS-PAGE without reduction of the sample and SP-B 
containing fractions (M r = 18 000) pooled accordingly. The 
pooled fractions were assayed for protein content by fluo- 
rescamine analysis in the presence of 0.1% SDS [24] and 
stored at 4°C. For all experiments, SP-B was dried under 
N 2 to remove the HCI and resolubilized in methanol (200 
/xg/mL) before use. Molecular weights of 36000 and 
9000 for SP-A and SP-B, respectively, were used for the 
calculation of protein molarity. 
2.3. Liposome preparation 
2. Materials and methods 
2.1. Materials 
Dipalmitoylphosphatidylcholine (DPPC) and egg phos- 
phatidylglycerol (egg PG) were purchased from Avanti 
Polar Lipids (Birmingham, AL). The purity of the 
phospholipids was verified by thin-layer chromatography 
[20]. Fluorescent lipid probes, N-(7-nitrobenz-2-oxa-l,3- 
diazol-4-yl)phosphatidylethanolamine (NBD-PE), and N- 
(lissamine rhodamine B sulfonyl)phosphatidylethanol- 
amine (RH-PE) were from Avanti Polar Lipids. Fluo- 
rescamine, 3(N-morpholino)-2-hydroxypropanesulfonic 
acid (MOPSO), and calcium chloride were from Sigma 
(St. Louis, MO). Organic solvents of HPLC grade were 
from Mallinckrodt (Paros, KY). 
2.2. Preparation of surfactant apoproteins 
Surfactant was isolated from lung lavage of patients 
who had alveolar proteinosis and from adult dogs, using 
A phospholipid mixture of DPPC-egg PG (7:3, w/w)  
was dried under N 2, then resuspended in 50 mM 
MOPSO/140 mM NaCI/0.1 mM EDTA buffer (pH 6.9 at 
37°C). The phospholipid suspension was then passed 
through an 'Extruder "~' (Lipex Biomembranes, Vancou- 
ver, Canada) under 50 to 500 lb/inch 2 argon pressure. The 
liposomes used for all experiments were obtained by series 
of 6 extrusions through 2 stacked 0.2 /~m, then through 
0.1 /xm polycarbonate filters. Liposome stock suspensions 
(1.0 M phospholipids) were stored at 4°C. 
2.4. Measurement of lipid mixing 
Lipid mixing was measured by the method of resonance 
energy transfer between non-exchangeable f uorophores 
[25]. The energy transfer of the two fluorophores NBD-PE 
and Rhodamine-PE used in our experiments remains lin- 
early proportional to their surface density in a lipid bilayer 
between surface densities of 0.1 and 1 M% [25]. In all our 
experiments, fluorophores were 1 M% of the total phos- 
pholipids in fluorescently labeled liposomes. Mixing of 
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labeled with unlabeled bilayers causes dilution of the 
fluorophores within the membranes and decrease of the 
energy transfer between them, resulting in an increase of 
NBD fluorescence. Mixtures of labeled:unlabeled (1:9) 
liposomes in buffer were continuously stirred in the tem- 
perature-regulated 2 mL cuvette of a Fluorolog 2 spectro- 
fluorometer (SPEX Industries, Edison, NJ, USA). A light- 
proof port allowed for injection of reagents without inter- 
ruption of the recording. Baseline fluorescence (0%) was 
that of the mixture before any addition of reagents, and 
maximum fluorescence (100%) that after addition of the 
non-ionic detergent C 12E8 (Calbiochem, San Diego). NBD 
fluorescence xcitation was set at 450 nm and emission 
was measured at 520 nm. 
2.5. Data analysis 
labeled liposomes, respectively. Since the ratio K/L  was 9 
in all our experiments: 
U = 90/(90 - I )  (4) 
for I < 90(% maximum). 
The quality of agreement between estimated and experi- 
mental values was evaluated by statistical analysis. R 2 
values were in most cases greater than 0.99. The root mean 
square error (RMSE) was about 1%, where: 
[i=~ ]1/2 
gmsE = £ ( Yci 2 4) (5) --Yei) / (n -  
i= l  
and n is the number of data points used, and Yci and Yei 
are calculated and experimental I(t) values, respectively. 
The factor (n - 4) represents he degrees of freedom. 
NBD fluorescence measurements for all experiments 
were sampled every 2 s and stored electronically. Final 
extents of fluorescence ( I )  were recorded 10 min after 
addition of the protein, and just before that of the deter- 
gent. 
In a selected number of experiments, we analyzed the 
kinetics of lipid mixing using the mathematical procedure 
based on a mass action model [26,27]. The model distin- 
guishes between two steps in the reaction. If V 1 represents 
primary lipid vesicles, A their aggregate and F the result- 
ing fusion product, the reaction can be described by: 
C f 
V I+V 1 ~A- -+F  (1) 
D 
The first step, aggregation, is reversible and of second-order 
with respect o the concentration of the reaction compo- 
nents. The second step includes destabilization and irre- 
versible lipid mixing and is of first-order with respects to 
the concentration of the reaction components. The current 
program considers aggregation-fusion products of orders 2 
to 8. Numerical estimates were derived for the aggregation 
rate constant C (M-1 s-1), the disaggregation rate con- 
stant D (s- I ), and the fusion rate constant f (s- 1 ) in Eq. 
(1). In addition, another parameter Ky, which describes the 
reduction in the fusion rate constant for liposomes that 
already fused once, was introduced. Kf, is defined by: 
f , . j=Kr* f l  I ( i , j>  1) (2) 
where i or j refer to the order of vesicles in a given fusion 
reaction. When i and j equal 1, then fq =f .  The parame- 
ter K/ accounts for the apparent slowing of the fusion 
process at later stages. 
The mean estimated number of vesicles per fusion 
product, N, can be derived from the following equation 
[28]: 
I= IO0*( K / (  K + L ) ) * (  N -1) /N  (3) 
where I is the final extent of fluorescence obtained (% 
maximum), K and L are the fractions of non labeled and 
3.  Resu l t s  
Both SP-A and SP-B were added to liposome suspen- 
sions out of their stock solutions, 5 mM Tris and methanol, 
respectively. The reagent volume added varied between 5 
and 40 /zL. Control experiments howed that identical 
volumes of Tris buffer and methanol alone did not cause 
detectable lipid mixing (data not shown). Representative 
tracings of recorded fluorescence are shown in Fig. 1. 
Fluorescence after addition of 100 nM SP-B (SP-B/lipid 
molar ratio = 0.4%) in the presence of 5 mM calcium at 
time 0 is displayed by the lower line, and in the presence 
of 5 mM calcium + 100 nM SP-A (SP-A/lipid molar 
ratio = 0.4%) by the upper line. As reported previously, 
SP-A enhanced the extent of fusion induced by SP-B [4]. 
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Fig. 1. Examples of fluorescence tracings used to measure final extents 
(I) and to estimate rate constants for the membrane fusion reaction. 100 
uM human SP-B alone (lower tracing), and 100 nM SP-B+dog SP-A 
(upper tracing) were added to a suspension f 25 /~M DPPC-egg PG 
liposomes in50 mM MOPSO, 150 mM NaC1, 5 mM CaCI 2 buffer, pH 
6.9, 37°C. The inset shows the estimated corresponding I values derived 
from analysis (open symbols) overlaying the experimental tr cings. 
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Fig. 2. Effects of lipid concentration  final extents of fusion (I0 rain). 
Increasing amounts of human SP-B were added to DPPC-PG liposomes 
at concentrations of 5 /~M (filled circles), 25 /~M (open diamonds), and 
100 /xM (filled triangles) phospholipids in 50 mM MOPSO, 150 mM 
NaC1, 5 mM CaCI 2 buffer, pH 6.9, 37°C. 
used in the analysis of lipid mixing kinetics. The values 
calculated by applying the mass action kinetic model to 
experimental data and represented here by open symbols 
overlaying the first 20 s of each experimental tracing, 
illustrate the close agreement between calculated values 
and experimental data. 
3.1. Effects of lipid concentration 
Increasing amounts of SP-B were added to DPPC-egg 
PG liposome suspensions prepared in three different con- 
centrations: 5, 25, and 100 /zM phospholipids. The fluo- 
rescence achieved 10 min after addition of the protein(s), 
I, is a measure of the lipid mixing that took place between 
vesicles and was plotted as a function of the protein/phos- 
pholipid ratios for each of the three liposome concentra- 
tions. We found a relationship between the extent of lipid 
mixing and the SP-B/l ipid ratio at all three liposome 
concentrations (Fig. 2). At low liposome concentration (5 
/xM phospholipids) higher SP-B/l ipid ratios were required 
to achieve fusion than at higher liposome concentration 
(> 25 /zM phospholipids), suggesting that liposome aggre- 
gation may be rate-limiting at low lipid concentrations. 
3.2. Effects of calcium and SP-A addition 
As noted in our previous studies [4], the addition of 5 
mM calcium by itself had a small effect on lipid mixing 
induced by SP-B (Fig. 3). In contrast, addition of SP-A 
and calcium markedly enhanced SP-B-induced lipid mix- 
ing, and this effect was dose-dependent (Fig. 4). Even at 
SP-B doses which by themselves caused undetectable ipid 
mixing (_< 0.2% SP-B/l ipid molar ratio), SP-A greatly 
augmented SP-B-induced lipid mixing (Fig. 3). 
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Fig. 3. Effects of temperature, calcium and SP-A addition on final extents 
of fusion (10 min) induced by SP-B. DPPC-PG liposomes (25 ~M) were 
in 50 mM MOPSO, 150 mM NaC1, 5 mM CaCI 2 buffer (pH 6.9). 
Increasing amounts of human SP-B were added at 20°C (triangles, dashed 
lines) and at 37°C (circles, solid lines), in the presence (filled symbols) or 
absence of 50 nM dog SP-A (SP-A/lipid molar atio = 0.2%; open 
symbols). At 37°C SP-B was also added in the presence ofexcess EDTA 
(crosses). 
and fusion ( f )  rate constants that best simulated the exper- 
imental data are shown in Table 1. The starting lipid 
concentration was 25 /zM in all cases analyzed. The 
calculated aggregation and fusion rate constants at various 
SP-B and SP-A/l ipid ratios are most consistent with the 
effects of SP-A on SP-B induced fusion being attributable 
to its aggregative properties. At the starting 0.4 M% 
SP-B/l ipid ratio, the aggregation rate constant, C, doubled 
in the presence of 100 nM SP-A (0.4 M% SP-A/l ipid 
ratio), but the fusion rate constant, f ,  remained unchanged 
(Table 1). The addition of SP-A also resulted in a dramatic 
increase in the average number of vesicles in a fusion 
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Fig. 4. Effects of SP-A concentration on final extents of fusion (10 min) 
induced by SP-B. DPPC-PG liposomes (25/.tM) were in 50 mM MOPSO, 
150 mM NaCI, 5 mM CaC12 buffer, pH 6.9, 37°C. Fluorescence was 
measured (open circles) after increasing amounts of dog SP-A were 
added to 20 nM human SP-B (SP-B/phospholipid molar atio = 0.08%). 
F.R. Poulain et al. / Biochimica et Biophysica Acta 1278 (1996) 169-175 
Table 1 
Estimates of number of vesicles per fusion products and rate constants for the lipid mixing reaction 
173 
Temperature SP-B/lipid SP-A/lipid N Rate constants Kf 
(C ° ) (%M/M) (%M/M) (Eq.(3)) C (x IOSM- I  s - t )  O(s - i )  f ( s_~)  
37 0.02 0.02 1.2 0.05-0.1 0.2 0.05-0.1 1/6 
37 0.02 0.4 1.9 1.3 0.2 0.1 1/6 
37 0.08 0,02 2.0 1.8 0.2 0.3 1/6 
37 0.08 0.4 100.0 3.2 0.2 0.3 1 (> 1/2) 
37 0.4 0.02 6.4 3.8 0.2 0.4 1 (> 1/2) 
37 0.4 0.4 > 100 6.0 0.2 0.6 1/6 
20 0.08 0.02 2.7 1.0 0.1 0.1 1/5 
20 0.08 0.4 2.1 4.0 0.1 0.02 1/5 
20 0.4 0.02 13.4 4.0 0.1 0.27 1/4 
20 0.4 0.4 11.9 6.0 0.1 0.17 l /4  
20 0.4 0 9.3 2.0 0.1 0.23 1/3 
37 0.4 0 2.9 3.0 0.2 0.6 1/3 
42 0.4 0 1.7 3.5 0.5 0.4 < 1/10 
Conditions are as explained in the methods. Phospholipid concentration is 25 /xM. Rate constants estimates for the aggregation (C), disaggregation (D) 
and fusion ( f )  steps of the lipid mixing process were calculated using the mass action kinetic model [26,27]. Ky is a correction factor for fusion rate 
constant for vesicles that already fused once. The estimated uncertainties in C, f ,  D and Kf are 20%, 30%, 50% and 50%, respectively. In certain cases, 
larger uncertainties are indicated. N is the estimated mean number of vesicles per aggregation-fusion product after 10 min of incubation. 
3.3. Effect of temperature 
Because temperature affects the physical state of lipid 
bilayers and influences the binding of proteins to the 
bilayer as well as the diffusion rate of bound proteins in 
the plane of the membrane, we studied the effect of 
temperature on lipid mixing at various SP-B/lipid ratios in 
the presence and absence of SP-A. We found that in the 
absence of added SP-A, final extents of lipid mixing after 
10 min increased slightly at 20°C vs. 37°C (Fig. 3). In 
contrast, lower temperature blunted the synergistic effect 
of SP-A (Fig. 3). 
We also analyzed the effect of temperature on the 
kinetics of membrane fusion in a limited number of cases 
(Table 1). In the presence of SP-B alone (0.4 M% SP- 
B/l ipid ratio), aggregation and fusion rate constants in- 
creased with temperature increasing from 20°C to 37°C. In 
the presence of both SP-A and SP-B, however, the aggre- 
gation rate constant remained unchanged when the temper- 
ature increased from 20°C to 37°C, again suggesting that 
SP-A mainly promotes the fusion reaction through its 
aggregative properties. 
4. Discussion 
This study was limited to liposomes with a fixed binary 
phospholipid composition to limit the matrix of variables 
investigated and allow us to focus primarily on the effect 
of protein-lipid stoichiometry on liposome fusion. The 
choice of 70% DPPC and 30% PG was based on the 
composition of surfactant and also to allow us to compare 
our results with those from previous tudies [4,38]. Addi- 
tionally, the results from studies with both SP-A [29] and 
SP-B [30,31] suggest specific interactions with PG may be 
important in surfactant function. Our conclusions, how- 
ever, cannot be immediately extended to the physiological 
state because the lipid composition clearly does not repro- 
duce the complexity of natural surfactant [32]. Further 
experiments will be required to assess such potentially 
important variables as cholesterol and unsaturated phos- 
phatidylcholines. Also, the method of adding SP-B to the 
pre-formed liposomes from a methanol solution may have 
influenced the results by protein losses to precipitation or 
the introduction of significant micro-heterogeneity in the 
stoichiometry of the lipoproteins formed. We did not at- 
tempt to compare the bulk phase SP-B content with the 
composition of the final lipoprotein products. 
With these reservations stated, our results show that 
SP-B is a very potent membrane fusogen. Fusion occurs 
even at bulk protein contents as low as 0.02 M% and is 
maximal between 0.5 and 1 M%, depending on the lipid 
concentration (Fig. 2). At the higher SP-B/lipid ratios the 
rates and extent of fusion we report are amongst he 
highest observed in similar systems with other proteins or 
peptides [27,33,34]. Precise quantitation of SP-B in lamel- 
lar bodies or secreted surfactant is difficult. The SP-B 
content of lamellar bodies is reported to range from 0.01- 
0.05 M% [35]. This estimate is based on protein recovered 
from a chromatography column and is likely to represent 
an underestimate of the true protein content. Provided 
other factors such as pH, ionic strength and lipid composi- 
tion do not significantly alter the fusogenic potency of 
SP-B, these estimates suggest he amount of SP-B present 
in lamellar bodies is sufficient o play a major role in the 
formation of the closely-packed sheets of lipids in these 
organelles. Temperature and Ca 2÷ both affect he aggrega- 
tion of PG containing liposomes, but very little effect of 
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calcium or temperature on the SP-B effect was observed in 
our studies. Our kinetic analysis, using a model and as- 
sumptions previously presented in detail [27], suggests the 
fusion rate constant was directly related to the SP-B/lipid 
ratio. This suggests the formation of lamellar bodies, as- 
suming the hypothesis giving SP-B a role in this process is 
correct, would be very dependent on the lamellar body 
SP-B content. The abnormal lamellar body morphology in 
infants with congenital absence of SP-B is consistent with, 
but does not prove, this idea [36]. 
Several investigators have studied the effects of SP-A, a 
large multivalent protein, on liposome aggregation. SP-A 
binds reversibly to liposomes of different compositions 
provided binding is carried out below the phase transition 
temperature of the lipids [29,37]. The binding is not depen- 
dent on calcium [29], but in the presence of calcium [12] 
and certain other divalent cations [38] SP-A induces mas- 
sive liposome aggregation. The calcium-induced aggrega- 
tion of liposomes correlates with calcium binding to spe- 
cific sites in SP-A and an induced aggregation of the 
protein even in the absence of lipids [39]. These results 
suggest SP-A aggregates liposomes by protein-protein 
cross-bridges. Although SP-A alone produces no evidence 
of fusion even when present in high amounts, a striking 
enhancement of SP-B induced fusion has been reported [4] 
and seen again in this study. This synergy was present 
even at concentrations of SP-B too low (< 0.02% molar 
ratio) to cause detectable fusion. 
By modeling the reaction in terms of a two step process 
of reversible aggregation leading to irreversible fusion 
products, we hoped to understand this synergy further. 
According to this model, SP-A enhances the aggregation 
rate of liposomes containing SP-B two to three fold, result 
which is consistent with previous qualitative studies with 
SP-A [12,38]. The model also predicts SP-A has little, if 
any, effect on the fusion rate constant. The almost total 
loss of protein synergy at 20°C also suggests SP-A-in- 
duced aggregation alone is sufficient o explain the en- 
hanced fusion at 37°C, when desaggregation rates are 
increased relative to those at lower temperature [40]. Our 
results with substitution of mellitin for SP-B, however, 
which showed no enhancement of fusion by SP-A [4], may 
be more consistent with more specific interactions between 
SP-A and SP-B than a simple two step model of SP-A 
induced aggregation followed by SP-B induced fusion 
allows. Whether the two proteins interact directly or 
through effects on the lipids, such as modulation of phase 
transitions or domain boundaries, remains to be estab- 
lished. By whatever mechanism, the net impact of protein 
synergy is dramatic and is quantitatively reflected in a 
dramatic increase in the estimated mean number of lipo- 
somes contributing to a single fusion product 10 min after 
the reaction begins. At certain protein stoichiometries the 
combined effects on aggregation and fusion result in a 
100-fold increase in this parameter. A better understanding 
of the mechanisms underlying protein synergy in surfac- 
tant structure will be necessary to progress on the impor- 
tant question of how these complex structures mediate the 
remarkable surface properties of this material. 
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